Cargando…
Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale
Tizanidine is an alpha-2 adrenergic agonist used commonly by medical professionals to treat patients' chronic spasticity, muscle spasms, and neuralgia usually associated with myofascial components. This medication is also used very frequently in detoxification centers on patients treated for an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836827/ https://www.ncbi.nlm.nih.gov/pubmed/36644068 http://dx.doi.org/10.7759/cureus.32492 |
_version_ | 1784868945082187776 |
---|---|
author | Goyal, Lokesh Mallick, Deobrat Zapata, Miana R Yashi, Kanica Chourasia, Prabal Surani, Salim |
author_facet | Goyal, Lokesh Mallick, Deobrat Zapata, Miana R Yashi, Kanica Chourasia, Prabal Surani, Salim |
author_sort | Goyal, Lokesh |
collection | PubMed |
description | Tizanidine is an alpha-2 adrenergic agonist used commonly by medical professionals to treat patients' chronic spasticity, muscle spasms, and neuralgia usually associated with myofascial components. This medication is also used very frequently in detoxification centers on patients treated for analgesic withdrawal, especially those who are suffering from rebound headaches due to the discontinuation of analgesics. Tizanidine is metabolized in the human body by the cytochrome P450 CYP1A2. On the other hand, ciprofloxacin is a common antibiotic belonging to the class of fluoroquinolones and is used to treat various infections. Ciprofloxacin inhibits the bacterial DNA-gyrase enzyme resulting in the destruction of the organism. Ciprofloxacin is also an inhibitor of the cytochrome P450 CYP1A2. Even though these two medications show obvious interaction still, however, both these medications are often prescribed together, and their interactions/contraindications are often overlooked by many physicians and other providers. We hereby describe the case report of the interaction between tizanidine and ciprofloxacin, along with the adverse outcome related to the concomitant use of these two drugs. |
format | Online Article Text |
id | pubmed-9836827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-98368272023-01-13 Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale Goyal, Lokesh Mallick, Deobrat Zapata, Miana R Yashi, Kanica Chourasia, Prabal Surani, Salim Cureus Family/General Practice Tizanidine is an alpha-2 adrenergic agonist used commonly by medical professionals to treat patients' chronic spasticity, muscle spasms, and neuralgia usually associated with myofascial components. This medication is also used very frequently in detoxification centers on patients treated for analgesic withdrawal, especially those who are suffering from rebound headaches due to the discontinuation of analgesics. Tizanidine is metabolized in the human body by the cytochrome P450 CYP1A2. On the other hand, ciprofloxacin is a common antibiotic belonging to the class of fluoroquinolones and is used to treat various infections. Ciprofloxacin inhibits the bacterial DNA-gyrase enzyme resulting in the destruction of the organism. Ciprofloxacin is also an inhibitor of the cytochrome P450 CYP1A2. Even though these two medications show obvious interaction still, however, both these medications are often prescribed together, and their interactions/contraindications are often overlooked by many physicians and other providers. We hereby describe the case report of the interaction between tizanidine and ciprofloxacin, along with the adverse outcome related to the concomitant use of these two drugs. Cureus 2022-12-13 /pmc/articles/PMC9836827/ /pubmed/36644068 http://dx.doi.org/10.7759/cureus.32492 Text en Copyright © 2022, Goyal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Family/General Practice Goyal, Lokesh Mallick, Deobrat Zapata, Miana R Yashi, Kanica Chourasia, Prabal Surani, Salim Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale |
title | Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale |
title_full | Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale |
title_fullStr | Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale |
title_full_unstemmed | Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale |
title_short | Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale |
title_sort | tizanidine toxicity from ciprofloxacin: a cautionary tale |
topic | Family/General Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836827/ https://www.ncbi.nlm.nih.gov/pubmed/36644068 http://dx.doi.org/10.7759/cureus.32492 |
work_keys_str_mv | AT goyallokesh tizanidinetoxicityfromciprofloxacinacautionarytale AT mallickdeobrat tizanidinetoxicityfromciprofloxacinacautionarytale AT zapatamianar tizanidinetoxicityfromciprofloxacinacautionarytale AT yashikanica tizanidinetoxicityfromciprofloxacinacautionarytale AT chourasiaprabal tizanidinetoxicityfromciprofloxacinacautionarytale AT suranisalim tizanidinetoxicityfromciprofloxacinacautionarytale |